Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better nurse training reduce ICU complications?

NCT ID NCT07796724

Knowledge-focused Sponsor: Hiroshima University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests whether a structured training program for ICU nurses, focusing on respiratory and renal care with case-based discussions, improves their clinical reasoning, knowledge, and collaboration with doctors. The study involves 140 participants, including nurses and mechanically ventilated patients in a tertiary ICU in Bangladesh. Researchers will compare nurse outcomes before and after training, and patient outcomes against historical data, to see if the training reduces ventilator-associated events, pneumonia, and acute kidney injury.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
evidence-based respiratory and renal care training with case-based discussion
What this could lead to
If effective, this training could improve nurses' clinical reasoning and collaboration, potentially reducing complications like ventilator-associated pneumonia and acute kidney injury in ICU patients.
What could go wrong
This is a single-center study with a moderate sample size, and patient outcomes are compared to historical data, which may introduce bias. The training's success depends on consistent implementation and may not generalize to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For nurses: * Registered nurses employed in the ICU at the time of enrollment * Involved in direct patient care * Willing to participate and provide informed written consent For Patients: * Age ≥18 years * Patients receive mechanical ventilation for at least ≥ 48 hours * Legal guardian of the patients who will provide informed written consent Exclusion Criteria: For nurses: * Nurses on long-term leave and study leave during the intervention period * Nurses working exclusively in administrative or managerial roles * Nurses who did not complete the pre-test assessment For Patients: * Patients mechanically ventilated for less than 48 hours. * Patients who have already developed VAE or VAP at ICU admission * Patients with end-stage renal disease on chronic dialysis prior to ICU admission * Readmissions to ICU during the same hospital stay

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute kidney injury Clinical reasoning Nurse-physician collaboration Nurses knowledge & practice Ventilator associated events Ventilator-associated pneumonia (VAP)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dhaka Medical College & Hospital

    Dhaka, Dhaka Division, 1000, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.